Top Searches
Advertisement

Equity Meets Elixirs—Shelter Pharma Eyes Capital Boost with Convertible Magic in June 26 Board Meet


Updated: June 23, 2025 14:22

Image Source: IPO Watch
Shelter Pharma Ltd (BSE: SHEH.BO) has stated that its Board of Directors will consider a proposal to raise funds through issue of Convertible Equity Warrants at its board meeting on June 26, 2025. This move is aimed to reinforce the company's capital base as it forays into future growth strategies.
 
1. What's on the Agenda?
  • The board will also discuss granting Convertible Equity Warrants—financial products convertible to equity shares on a later date.
  • The issue will be done through preferential allotment and/or private placement, subject to shareholder and regulatory approvals.
  • Key details such as warrant numbers, issue price, and name of proposed allottees will also be discussed in the meeting.
2. Why It Matters
  • Shelter Pharma is a ISO- and GMP-certified manufacturer of Ayurvedic medicine and animal supplements.
  • The planned fund-raising could help the company expand output capacity, fund research and development, or strengthen its distribution network.
  • This is consistent with a broader pattern of small-cap pharma companies raising funds from equity markets to fuel growth.
3. Market Snapshot
  • What: Shelter Pharma shares
  • When: June 24, 2025
  • At: ₹40.00, down 2.43% on the day.
The 52-week high/low is ₹69.70/₹35.70 and the market capitalisation is approximately ₹46 crore. 
 
Sources: Rediff Money, Economic Times, Screener

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement